Article
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
1 Dec 2016
Abstract excerpt
BACKGROUND: Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin's lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic value for MCL. Long non-coding RNAs (lncRNAs) have emerged as key regulators in cancers, including MCL. Metastasis-associated lung adenocarcinoma transcript 1(MALAT1), a lncRNA located at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
